2018

PND12 — Natalizumab versus glatimer acetate in relapsing-remitting multiple sclerosis: a network meta-analysis
  • Источник:
    Value in Health Volume 21, Supplement 3, October 2018, Page S331
  • Авторы:
    M. Sultanov1 A. Almadiyeva2 K. Absattarova2 Y. Semenova3 1) Nazarbayev University, Astana, Kazakhstan 2) Kazakh Agency for Health Technology Assessment, Astana, Kazakhstan 3) Semey State Medical University, Semey, Kazakhstan